The research service shows that the global breast cancer imaging device industry bringing the latest technology innovations. According to the report, these innovative technologies include ionizing breast tomosynthesis technology and magnetic resonance imaging (MRI) and non-ionizing ultrasound.
Breast cancer is one of the major causes of death due to cancer among women. For early detection and in time intervention, the regular cancer screening is compulsory. The common method of screening for breast cancer is mammography. The old methods of breast cancer screening are however plagued by various challenges.
Innovations in medical technology have increased the sensitivity and accuracy of the diagnosis and provided a closer step at safety aspects which includes less use of ionizing radiation.
Every 1 in 8 women (about 12 percent) in the United States will have breast cancer in her lifetime. Breast cancer is the top most common cancers in American women. It can occur in both men and women but most common in women. According to estimation 41,760 women and 500 men will die from breast cancer every year. Metastatic breast cancers are the major cause. Currently, the average risk of breast cancer development in American women in their lifetime is 13%. There are currently more than 3.5 million survivors of breast cancer in the U.S according to the American Cancer Society.
These advances in technologies enable the early and accurate diagnosis of breast cancer.
- Methodology of research
- Key Findings
Overview of Industry and Snapshot of Technology
- New emerging statistical trends of breast cancer
- Advance innovations to address unmet medical needs
- Segmentation of imaging technologies
- Breast tomosynthesis addressing the quality challenges related to mammography
- Production of high definition clear images by the low-dose mammography
- Better images as compared to traditional mammography by breast tomosynthesis
- Sharp microcalcification images by low-dose mammography system
- Accurate tumor margins by 3D tomosynthesis
- Breast ultrasound as a complementary tool to screening by mammography
- FDA- approved ultrasound technology for breast imaging
- Ultrasound technology for detection in dense tissues of the breast.
- MRI for evaluating abnormalities in mammography
- Key MRI system for breast imaging
- Impact Analysis
- Improved efficiency and accuracy by artificial intelligence (Al)
- FDA-approved Al diagnosis system for mammography
- FDA-approved Al diagnosis for ultrasound imaging and MRI
- Venture Private funding directed for Al and Ultrasound technologies
- Notable Private Funding
- Assessment of alliance and partnership in the industry
- Partnerships for strengthening Al in the imaging market
- Partnership deals for improving breast cancer technologies
- Latest FDA policies to modernize these mammography services for breast cancer patients
Growth Opportunities and Technology Roadmap
- Radiogenomics and deep learning paving the future way for breast cancer imaging
- Cost-effectiveness, device portability, and improved accuracy enhances growth opportunities
- Imaging Technology Trend
- Mobile Point-of-care screening
- High-resolution images by 4D breast cancer imaging
- Enhance Patient comfort by imaging devices
- Strategic measures for the future of the industry